TMOD-49. ANTITUMOR EFFICACY OF ANTI-PDL1 IN ACTH-SECRETING PITUITARY ADENOMAS: AN IMMUNOTHERAPEUTIC APPROACH FOR CUSHING’S DISEASE

BACKGROUND: Cushing’s disease (CD) is caused by an ACTH-secreting pituitary adenoma that causes severe patient morbidity. First-line treatment for CD is surgical adenomectomy, but 25% of these patients will recur within 5-years. Targeting immune checkpoint Program Death Ligand-1 (PDL1) has emerged a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Elsamadicy, Aladine A, Farber, S Harrison, Chongsathidkiet, Pakawat, Kemeny, Hanna, Woroniecka, Karolina, Cui, Xiuyu, Dunn, Ian, Fecci, Peter
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692082/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.1085
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars